ijms-logo

Journal Browser

Journal Browser

Emerging Biological and Molecular Targets in Schizophrenia

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 30 October 2025 | Viewed by 1028

Special Issue Editor


E-Mail Website
Guest Editor
1. Department of Clinical Neurosciences, IRCCS San Raffaele, Milan, Italy
2. Department of Humanities and Life Sciences, University School for Advanced Studies IUSS, Pavia, Italy
Interests: schizophrenia; psychedelics; psychopharmacology; clozapine; kynurenine pathway; inflammation; cognition; language

Special Issue Information

Dear Colleagues,

Schizophrenia is characterized by several symptom dimensions that show high heterogeneity in terms of biological underpinnings. Licensed pharmacological treatments can manage positive symptoms quite well, although not always satisfactorily. However, negative and cognitive symptoms still represent unmet clinical needs only partially addressed by drugs and rehabilitations strategies. Thus, the identification of new targets of treatment is of paramount importance to ameliorate daily functioning and quality of life for people with schizophrenia. Mounting evidence points to a multitude of new potential biological/molecular targets for pharmacological and non-pharmacological treatments that go beyond the conventional dopaminergic system. Modulation of NMDARs and other receptors (cholinergic, GABA), neuroplasticity, and synaptic homeostasis, as well as Trace Amine-Associated Receptors (TAARs), the kynurenine pathway—regarding, in particular, kynurenic acid (KYNA), and neuroinflammation are just some of the candidate systems. Some preclinical evidence, combined with old clinical studies, also lays the foundation for starting to consider psychedelics as a possible treatment for deficit-schizophrenia. In conclusion, all papers with the aim of disentangling possible determinants of illness and/or identifying new possible targets for pharmacological and non-pharmacological interventions for schizophrenia are welcome. Opinion papers and perspectives with a strong scientific rationale are welcome as well.

Dr. Jacopo Sapienza
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • schizophrenia
  • cognition
  • negative symptoms
  • synapses
  • kynurenine pathway
  • TAAR1
  • psychedelics
  • new treatments

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

13 pages, 692 KB  
Brief Report
Differential Association of the DISC1 Interactome in Hallucinations and Delusions
by Araceli Gutiérrez-Rodríguez, Alma Delia Genis-Mendoza, Jorge Ameth Villatoro-Velázquez, María Elena Medina-Mora and Humberto Nicolini
Int. J. Mol. Sci. 2025, 26(17), 8738; https://doi.org/10.3390/ijms26178738 - 8 Sep 2025
Viewed by 583
Abstract
Multiple genes within the DISC1 (Disrupted-in-Schizophrenia-1) interactome have been implicated in psychotic disorders, which are characterized by hallucinations, delusions, negative symptoms, and disorganized behavior. However, the genetic associations of specific psychotic symptoms remain poorly understood. Methods: We conducted a genetic association analysis of [...] Read more.
Multiple genes within the DISC1 (Disrupted-in-Schizophrenia-1) interactome have been implicated in psychotic disorders, which are characterized by hallucinations, delusions, negative symptoms, and disorganized behavior. However, the genetic associations of specific psychotic symptoms remain poorly understood. Methods: We conducted a genetic association analysis of the DISC1 interactome for hallucinations and delusions in schizophrenia and bipolar disorder, using single-nucleotide polymorphism (SNP), gene, and gene-set approaches. Results: Our findings showed an association between the SNP rs6754640 in the NRXN1 gene and auditory hallucinations. Additionally, rs10263196 (EXOC4), rs7076156 (ZNF365), and nine NRXN1 SNPs were associated with delusions of reference, while rs17039676 (NRXN1) was linked to persecutory delusions. At the gene level, NRG1 and PCM1 were related to auditory hallucinations. The NRXN1, APP, EXOC4, and NUP210 genes were associated with delusions of reference, whereas NRG1 and APP were linked to persecutory delusions. Gene-set analysis indicated that pathways related to the regulation of neuronal structure and function were involved in auditory hallucinations, while cellular transport regulation pathways were associated with persecutory delusions. Conclusions: This study emphasizes the polygenic architecture of psychosis and suggests that distinct molecular mechanisms contribute to different types of hallucinations and delusions. Full article
(This article belongs to the Special Issue Emerging Biological and Molecular Targets in Schizophrenia)
Show Figures

Figure 1

Back to TopTop